Equities
Health CarePharmaceuticals & Biotechnology
  • Price (GBX)836.50
  • Today's Change0.50 / 0.06%
  • Shares traded334.55k
  • 1 Year change68.58%
  • Beta-0.0101
Data delayed at least 20 minutes, as of Jul 23 2019 16:35 BST.
More ▼

Forecasts data is unavailable for this security.

Consensus recommendation

As of Jul 19, 2019, the consensus forecast amongst 6 polled investment analysts covering BTG plc advises investors to hold their position in the company. This has been the consensus forecast since the sentiment of investment analysts deteriorated on Nov 26, 2018. The previous consensus forecast advised that BTG plc would outperform the market.
  • 1yr ago
  • 3M ago
  • 2M ago
  • 1M ago
  • Latest
Select bar for recommendation details.
RecommendationsLatest
Buy3
Outperform0
Hold3
Underperform0
Sell0

Share price forecast

The 7 analysts offering 12 month price targets for BTG plc have a median target of 840.00, with a high estimate of 840.00 and a low estimate of 665.00. The median estimate represents a 0.48% increase from the last price of 836.00.
High0.5%840.00
Med0.5%840.00
Low-20.5%665.00

Dividends

Historical dividend information is not available for BTG PLC.
Div growth (TTM)--
More ▼

Earnings history & estimates

On Jul 18, 2019, BTG plc reported semi annual 2019 earnings of 0.0797 per share.
Average growth rate+17.92%
BTG plc reported annual 2019 earnings of 0.3667 per share on Jul 18, 2019.
The next earnings announcement from BTG plc is expected the week of Jul 16, 2020.
Average growth rate+25.34%
More ▼

Revenue history & estimates

BTG plc reported semi annual 2019 revenues of 333.49m. This was 19.45% above the prior year's period results.
Average growth rate-12.73%
BTG plc had revenues for the full year 2019 of 728.60m. This was 17.42% above the prior year's results.
Average growth rate+18.84%
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.